| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |